Clinical Trial Update: Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating allogeneic bone marrow transplantation for severe osteogenesis imperfecta has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteogenesis Imperfecta

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Osteogenesis Imperfecta | Phase 1 | Status: COMPLETED